MicroRNA loaded edible nanoparticles: an emerging personalized therapeutic approach for the treatment of obesity and metabolic disorders
Authors:
Open Access
- 1 January 2022
- journal article
- editorial
- Published by Ivyspring International Publisher in Theranostics
- Vol. 12 (6) , 2631-2634
Abstract
Obesity is a metabolic chronic disease whose prevalence is strongly growing in the last years, reaching pandemic proportions. Nowadays weight loss, achieved through lifestyle changes, is the first line therapeutic objective, although great inter-individual variabilities influence response to treatment, suggesting the involvement of epigenetic factors. In this contest, there is increasing recognition of the role of small RNA molecules, particularly microRNAs in the epigenetic regulation of genes involved in adipose tissue and glucose metabolism and several microRNAs have been found to be dysregulated in obesity and metabolic diseases. The development of novel personalized therapeutic strategies using microRNAs bears promise. However, the application of naked microRNAs has been hampered by their low specificity and sensitivity. In a recent issue of Theranostics, Kumar et al. explored the possibility of microRNA delivery through ginger-derived nanoparticles (GDNPs) as an alternative therapeutic approach for obesity treatment.Keywords
This publication has 18 references indexed in Scilit:
- Promises of Nanotherapeutics in ObesityTrends in Endocrinology & Metabolism, 2019
- The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and diseaseNature Reviews Immunology, 2019
- Genetics of obesity: what genetic association studies have taught us about the biology of obesity and its complicationsThe Lancet Diabetes & Endocrinology, 2018
- Hyperpalatability and the Generation of Obesity: Roles of Environment, Stress Exposure and Individual DifferenceCurrent Obesity Reports, 2018
- Small non coding RNAs in adipocyte biology and obesityMolecular and Cellular Endocrinology, 2017
- Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancerBiomaterials, 2016
- Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse EventsJAMA, 2016
- Ginger‐derived nanoparticles protect against alcohol‐induced liver damageJournal of Extracellular Vesicles, 2015
- Aryl Hydrocarbon Receptor Deficiency Enhances Insulin Sensitivity and Reduces PPAR-α Pathway Activity in MiceEnvironmental Health Perspectives, 2011
- Pathophysiology of insulin resistance in human diseasePhysiological Reviews, 1995